Sio Capital Management, LLC - EUCRATES BIOMEDICAL ACQU COR ownership

EUCRATES BIOMEDICAL ACQU COR's ticker is EUCRU and the CUSIP is G3141W114. A total of 15 filers reported holding EUCRATES BIOMEDICAL ACQU COR in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Sio Capital Management, LLC ownership history of EUCRATES BIOMEDICAL ACQU COR
ValueSharesWeighting
Q1 2023$2,578,749
+3.9%
248,6740.0%1.28%
+38.9%
Q4 2022$2,481,767
-0.4%
248,6740.0%0.92%
+15.9%
Q3 2022$2,492,0000.0%248,6740.0%0.79%
-15.4%
Q2 2022$2,492,000
+1.6%
248,6740.0%0.94%
+15.4%
Q1 2022$2,452,000
-1.2%
248,6740.0%0.81%
+8.4%
Q4 2021$2,482,000
+0.3%
248,6740.0%0.75%
-5.2%
Q3 2021$2,474,000
-19.2%
248,674
-17.1%
0.79%
+3.7%
Q2 2021$3,060,000
+1.9%
300,0000.0%0.76%
+24.8%
Q1 2021$3,004,000
-6.1%
300,0000.0%0.61%
-6.9%
Q4 2020$3,198,000300,0000.66%
Other shareholders
EUCRATES BIOMEDICAL ACQU COR shareholders Q4 2021
NameSharesValueWeighting ↓
Sio Capital Management, LLC 248,674$2,452,0000.81%
Wealthspring Capital LLC 138,373$1,365,0000.27%
Cowen Investment Management LLC 100,000$986,0000.21%
Integrity Capital Management (HK) Ltd 3,800$37,0000.19%
Sage Mountain Advisors LLC 94,640$933,0000.15%
Schechter Investment Advisors, LLC 82,802$816,0000.08%
Verition Fund Management LLC 397,603$3,928,0000.05%
Magnetar Financial LLC 450,000$4,446,0000.05%
HGC Investment Management Inc. 79,150$781,0000.05%
RIVERNORTH CAPITAL MANAGEMENT, LLC 75,650$747,0000.03%
View complete list of EUCRATES BIOMEDICAL ACQU COR shareholders